McEnany Patrick J 的 Form 4 申報
Catalyst Pharmaceuticals, Inc.（CPRX），2022/8/19 申報
- 申報編號
- 0001161697-22-000399
- 申報時間
- 2022/8/19
- 交易日
- 2022/8/18-8/19
- 申報延遲
- 1 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 10 筆非衍生性交易、5 筆衍生性交易。公開市場賣出合計 $420.3 萬。交易後 1 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| McEnany Patrick JCIK 0000929985 | 董事、高階主管（總裁、執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/8/18 | Common stock, par value $0.001 per share | M行使選擇權取得 | +25,000 | $2.53 | +$63,250 | 4,955,217 | 直接 | |
| 2022/8/18 | Common stock, par value $0.001 per share | S賣出處分 | −25,000 | $13.93F1,F6 | −$348,250 | 4,930,217 | 直接 | |
| 2022/8/18 | Common stock, par value $0.001 per share | M行使選擇權取得 | +50,000 | $2.53 | +$126,500 | 4,980,217 | 直接 | |
| 2022/8/18 | Common stock, par value $0.001 per share | S賣出處分 | −50,000 | $13.93F2,F6 | −$696,500 | 4,930,217 | 直接 | |
| 2022/8/18 | Common Stock, par value $0.001 per share | M行使選擇權取得 | +50,000 | $2.53 | +$126,500 | 4,980,217 | 直接 | |
| 2022/8/18 | Common stock, par value $0.001 per share | S賣出處分 | −50,000 | $13.96F3,F6 | −$698,000 | 4,930,217 | 直接 | |
| 2022/8/18 | Common stock,. par value $0.001 per share | M行使選擇權取得 | +50,000 | $2.53 | +$126,500 | 4,980,217 | 直接 | |
| 2022/8/18 | Common stock, par value $0.001 per share | S賣出處分 | −50,000 | $13.95F4,F6 | −$697,500 | 4,930,217 | 直接 | |
| 2022/8/19 | Common stock, par value $0.001 per share | M行使選擇權取得 | +125,000 | $2.53 | +$316,250 | 5,055,217 | 直接 | |
| 2022/8/19 | Common stock, par value $0.001 per share | S賣出處分 | −125,000 | $14.10F5,F6 | −$1,762,500 | 4,930,217 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/8/18 | Common Stock | M行使選擇權處分 | −25,000 | $0.00 | $0 | 3,640,834 | 直接 | |
| 2022/8/18 | Common Stock | M行使選擇權處分 | −50,000 | $0.00 | $0 | 3,590,834 | 直接 | |
| 2022/8/18 | Common Stock | M行使選擇權處分 | −50,000 | $0.00 | $0 | 3,540,834 | 直接 | |
| 2022/8/18 | Common Stock | M行使選擇權處分 | −50,000 | $0.00 | $0 | 3,490,834 | 直接 | |
| 2022/8/19 | Common Stock | M行使選擇權處分 | −125,000 | $0.00 | $0 | 3,365,834 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Shares were sold in various lots from $13.93 to $13.97 per share. The listed sales price represents a weighted average price for the shares sold.
表 I 有 1 筆交易的價格引用這則附註。
- F2
Shares were sold in various lots from $13.93 to $13.94 per share. The listed sales price represents a weighted average price for the shares sold.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Shares were sold in various lots from $13.95 to $14.00 per share. The listed sales price represents a weighted average price for the shares sold.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Shares were sold in various lots from $13.95 to $13.98 per share. The listed sales price represents a weighted average price for the shares sold.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Shares were sold in various lots from $14.05 to $14.14 per share. The listed sales price represents a weighted average price for the shares sold.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Shares were sold to cover the exercise price of options, tax withholding requirements (if applicable) and for personal reasons. The shares were not sold as a result of any agreement with the Company and Mr. McEnany remains an officer of the company.
表 I 有 5 筆交易的價格引用這則附註。